Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
| Image |  |
|---|---|
| Description | scientific article published on 01 May 2020 |
| Author/s |
author: Knut Liestøl Harald Holte Signe Spetalen Øystein Fluge Mats Jerkeman |
| Publication date | May 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |